WallStreetZenWallStreetZen

NASDAQ: CYCN
Cyclerion Therapeutics Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

CYCN past revenue growth

How has CYCN's revenue growth performed historically?
Company
-100%
Industry
145.73%
Market
17.2%
CYCN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CYCN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

CYCN earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$5.3M
Current Profit Margin
0%

CYCN Return on Equity

Current Company
-63.3%
Current Industry
-63.5%
Current Market
188%
CYCN's Return on Equity (-63.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when CYCN announces earnings.

CYCN Return on Assets

Current Company
-42%
Current Industry
2.9%
CYCN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CYCN Return on Capital Employed

Current Company
-49.8%
Current Industry
19.5%
CYCN has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CYCN vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CYCN$0.00-$5.62M-$5.26M-100.00%N/A
BRTX$145.80k-$14.16M-$14.42M+5.61%N/A
NCNA$0.00-$40.33M-$35.43MN/AN/A
PYPD$0.00-$21.05M-$23.87MN/A+28.76%
ASLN$12.00M-$39.41M-$44.22M+41.42%N/A
View Top Biotech Stocks

CYCN earnings dates

Next earnings date
May 14, 2024

Cyclerion Therapeutics Earnings & Revenue FAQ

What were CYCN's earnings last quarter?

On Invalid Date, Cyclerion Therapeutics (NASDAQ: CYCN) reported Q4 2023 earnings per share (EPS) of -$0.70, up 78.92% year over year. Total Cyclerion Therapeutics earnings for the quarter were -$1.69 million. In the same quarter last year, Cyclerion Therapeutics's earnings per share (EPS) was -$3.32.

If you're new to stock investing, here's how to buy Cyclerion Therapeutics stock.

What was CYCN's earnings growth in the past year?

As of Q2 2024, Cyclerion Therapeutics's earnings has grown year over year. Cyclerion Therapeutics's earnings in the past year totalled -$5.26 million.

What is CYCN's earnings date?

Cyclerion Therapeutics's earnings date is Invalid Date. Add CYCN to your watchlist to be reminded of CYCN's next earnings announcement.

What was CYCN's revenue last quarter?

On Invalid Date, Cyclerion Therapeutics (NASDAQ: CYCN) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Cyclerion Therapeutics's revenue was $0.00.

What was CYCN's revenue growth in the past year?

As of Q2 2024, Cyclerion Therapeutics's revenue has grown -100% year over year. This is 245.73 percentage points lower than the US Biotechnology industry revenue growth rate of 145.73%. Cyclerion Therapeutics's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.